Ascendis Pharma A/S (ASND)
228.03
+0.16
(+0.07%)
USD |
NASDAQ |
Oct 05, 16:00
228.35
+0.32
(+0.14%)
After-Hours: 20:00
Ascendis Pharma Market Cap : 14.98B for Oct. 5, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 05, 2026 | 14.98B |
| October 02, 2026 | 14.96B |
| October 01, 2026 | 14.93B |
| September 30, 2026 | 14.96B |
| September 29, 2026 | 14.98B |
| September 28, 2026 | 15.11B |
| September 25, 2026 | 14.82B |
| September 24, 2026 | 15.15B |
| September 23, 2026 | 14.65B |
| September 22, 2026 | 15.60B |
| September 21, 2026 | 15.60B |
| September 18, 2026 | 15.55B |
| September 17, 2026 | 15.70B |
| September 16, 2026 | 16.27B |
| September 15, 2026 | 15.75B |
| September 14, 2026 | 17.40B |
| September 11, 2026 | 17.31B |
| September 10, 2026 | 17.16B |
| September 09, 2026 | 17.13B |
| September 08, 2026 | 17.74B |
| September 04, 2026 | 17.77B |
| September 03, 2026 | 17.81B |
| September 02, 2026 | 17.56B |
| September 01, 2026 | 17.09B |
| August 31, 2026 | 17.27B |
| Date | Value |
|---|---|
| August 28, 2026 | 16.28B |
| August 27, 2026 | 16.38B |
| August 26, 2026 | 16.43B |
| August 25, 2026 | 16.61B |
| August 24, 2026 | 16.55B |
| August 21, 2026 | 16.63B |
| August 20, 2026 | 16.73B |
| August 19, 2026 | 17.05B |
| August 18, 2026 | 16.34B |
| August 17, 2026 | 16.25B |
| August 14, 2026 | 16.32B |
| August 13, 2026 | 16.17B |
| August 12, 2026 | 16.78B |
| August 11, 2026 | 16.72B |
| August 10, 2026 | 16.79B |
| August 07, 2026 | 15.86B |
| August 06, 2026 | 15.52B |
| August 05, 2026 | 15.17B |
| August 04, 2026 | 15.19B |
| August 03, 2026 | 15.12B |
| July 31, 2026 | 15.15B |
| July 30, 2026 | 15.59B |
| July 29, 2026 | 15.66B |
| July 28, 2026 | 15.80B |
| July 27, 2026 | 15.74B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioMarin Pharmaceutical, Inc. | 11.14B |
| Novo Nordisk A/S | 125.60B |
| Evaxion AS | 26.27M |
| Genmab A/S | 22.97B |
| Zealand Pharma A/S | 2.793B |
Market Cap Related Metrics
| PE Ratio | 17.37 |
| PS Ratio | 11.91 |
| Price to Book Value | 9.118 |
| Price to Free Cash Flow | 37.38 |
| Price | 228.03 |
| Earnings Yield | 5.76% |
| Operating PE Ratio | 115.41 |
| Normalized PE Ratio | 17.37 |